The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
26/12/2016 - 5 minutes
GPCR
Drugging the Undruggable: New Acquisition to Boost GPCR Drugs
Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its…
30/11/2016 - 2 minutes
Structural Biology meets Drug Discovery in this Cool Company
After an amazing day in Paris for Labiotech Refresh, we head back to Germany to…
25/11/2016 - 1 minute
These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’
GPCRs have spelled “dead end” for many a biotech and academic endeavor. I sat down…
23/11/2016 - 4 minutes
Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech
Heptares Therapeutics is licensing its portfolio of novel candidates for neurological diseases, including one for Alzheimer's,…
07/04/2016 - 3 minutes
A Relief for Migraines at last? The Biotech race for the Ultimate Cure
A Migraine is more than just a headache; it is a neurological disorder affecting a…
17/03/2016 - 4 minutes
Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal
Heptares Therapeutics from the UK has landed Pfizer in a huge potential $1.9Bn deal for…
30/11/2015 - 2 minutes
The UK-Israeli €378M Small-Molecule Offensive Against Migraines
The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up…
26/11/2015 - 2 minutes
A reliable technology to develop the next generation of GPCR targeted medicines
You must have heard of GPCRs, or more specifically G protein-coupled receptors. Doesn’t ring a…
07/09/2015 - 4 minutes
A $500 Million Deal to Reactivate T-cells’ Anti-cancer Response
Heptares Therapeutics, the GPCR-targeted drug company, and British pharma giant AstraZeneca entered a new collaboration…
10/08/2015 - 2 minutes
MorphoSys Tackles the Technical Challenge of GPCR-targeted Drugs
Germany-based MorphoSys AG announced today that its partner Heptares Therapeutics, has initiated a therapeutic antibody…
31/07/2015 - 3 minutes
